» Articles » PMID: 28502089

Association Between Cytokine Profile and Transcription Factors Produced by T-cell Subsets in Early- and Late-onset Pre-eclampsia

Overview
Journal Immunology
Date 2017 May 15
PMID 28502089
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Pre-eclampsia (PE) is an obstetric pathology characterized by abnormal activation of the innate and adaptive immune systems dependent on the imbalance of T helper subsets. The present study aimed to evaluate the gene and protein expression of T helper type 1 (Th1)/Th2/Th17/regulatory T (Treg) cell transcription factors in peripheral blood lymphocytes from pregnant women with PE employing quantitative RT-PCR and flow cytometry techniques, as well as the cytokine profile produced by these CD4 T-cell subsets in the plasma of pregnant women with PE, classified as early-onset PE (n = 20), late-onset PE (n = 20) and normotensive pregnant women (n = 20). Results showed a higher percentage of CD4 T cells expressing the RORc transcription factor (Th17) and a lower percentage of cells expressing FoxP3 (Treg) in women with early-onset PE compared with late-onset PE and normotensive groups. A lower gene expression of GATA-3 transcription factor was detected in cells of women with early-onset PE compared with the late-onset PE group. Endogenous plasma levels of interleukin-6 (IL-6), IL-17 and tumour necrosis factor-α were significantly higher in the early-onset PE group than in the late-onset PE and normotensive groups, whereas IL-4 (Th2 profile) and IL-22 (Th17 profile), were not significantly different between the studied groups. The endogenous levels of transforming growth factor-β and IL-10 were significantly lower in the pre-eclamptic than in the normotensive groups of the same gestational age, with a significant difference between early- and late-onset PE. The results show that in women with PE there is an imbalance between inflammatory and anti-inflammatory profiles in CD4 T-cell subsets, with polarization to Th17 profiles in the early-onset PE, considered as the severe form of PE.

Citing Articles

Understanding the role of immune-mediated inflammatory disease related cytokines interleukin 17 and 23 in pregnancy: A systematic review.

Plug A, Barenbrug L, Moerings B, de Jong E, van der Molen R J Transl Autoimmun. 2025; 10:100279.

PMID: 40035074 PMC: 11874717. DOI: 10.1016/j.jtauto.2025.100279.


A comprehensive review of the roles of T-cell immunity in preeclampsia.

Peng X, Chinwe Oluchi-Amaka I, Kwak-Kim J, Yang X Front Immunol. 2025; 16:1476123.

PMID: 39981257 PMC: 11841438. DOI: 10.3389/fimmu.2025.1476123.


Importance of STAT3 signaling in preeclampsia (Review).

Marzioni D, Piani F, Di Simone N, Giannubilo S, Ciavattini A, Tossetta G Int J Mol Med. 2025; 55(4).

PMID: 39918020 PMC: 11878484. DOI: 10.3892/ijmm.2025.5499.


A Narrative Review on the Pathophysiology of Preeclampsia.

Torres-Torres J, Espino-Y-Sosa S, Martinez-Portilla R, Borboa-Olivares H, Estrada-Gutierrez G, Acevedo-Gallegos S Int J Mol Sci. 2024; 25(14).

PMID: 39062815 PMC: 11277207. DOI: 10.3390/ijms25147569.


Deciphering the immunological interactions: targeting preeclampsia with Hydroxychloroquine's biological mechanisms.

Gajic M, Schroder-Heurich B, Mayer-Pickel K Front Pharmacol. 2024; 15:1298928.

PMID: 38375029 PMC: 10875033. DOI: 10.3389/fphar.2024.1298928.


References
1.
Raghupathy R . Cytokines as key players in the pathophysiology of preeclampsia. Med Princ Pract. 2013; 22 Suppl 1:8-19. PMC: 5586811. DOI: 10.1159/000354200. View

2.
Arikan D, Aral M, Coskun A, Ozer A . Plasma IL-4, IL-8, IL-12, interferon-γ and CRP levels in pregnant women with preeclampsia, and their relation with severity of disease and fetal birth weight. J Matern Fetal Neonatal Med. 2011; 25(9):1569-73. DOI: 10.3109/14767058.2011.648233. View

3.
Redman C, Sargent I . Latest advances in understanding preeclampsia. Science. 2005; 308(5728):1592-4. DOI: 10.1126/science.1111726. View

4.
Santner-Nanan B, Peek M, Khanam R, Richarts L, Zhu E, Fazekas de St. Groth B . Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia. J Immunol. 2009; 183(11):7023-30. DOI: 10.4049/jimmunol.0901154. View

5.
Gervasi M, Chaiworapongsa T, Pacora P, Naccasha N, Yoon B, Maymon E . Phenotypic and metabolic characteristics of monocytes and granulocytes in preeclampsia. Am J Obstet Gynecol. 2001; 185(4):792-7. DOI: 10.1067/mob.2001.117311. View